OR WAIT null SECS
Patricia Van Arnum was executive editor of Pharmaceutical Technology.
April 16, 2009
The United States Pharmacopeial (USP) Convention signed a memorandum of understanding (MOU) with the Federal Service on Surveillance in Healthcare and Social Development of the Russian Federation (Roszdravnadzor) last week in Moscow.
April 09, 2009
Pfizer outlined the progress of its late-stage pipeline last week and announced this week plans to separate its research activities into two organizations, one focused on small molecules and the other on biologics, pending the closure of its pending acquisition with Wyeth.
Following several years of debate, the Senate Judiciary Committee voted 15?4 last week to approve a comprise patent reform bill, the "Patent Reform Act of 2009" (S. 515).
April 08, 2009
The financial crisis is adding further injury to already weakened prospects for the pharmaceutical industry.
Follow-on biologics or biosimilars offer a niche growth market for the pharmaceutical industry. As the process for establishing a regulatory pathway for biosimilars is debated, companies, including Big Pharma, are positioning themselves to gain this piece of the pharmaceutical pie.
April 02, 2009
The US Senate introduced a bipartisan bill (S. 726) on Mar. 26, 2009, which establishes a regulatory pathway for approval of biosimilars.